BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang R, Liu X, Sun X, Wang J, Huang Z, Li C, Li Z, Zhou J, Pu Y, Ying Z, Yin Q, Zhao Z, Zhang L, Lei J, Bao W, Jiang Y, Dou Y, Li J, Yang H, Cai W, Deng Y, Che Y, Shi L, Sun M. Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population. Vaccine 2021;39:1463-71. [PMID: 33487470 DOI: 10.1016/j.vaccine.2021.01.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Piniaeva A, Ignatyev G, Kozlovskaya L, Ivin Y, Kovpak A, Ivanov A, Shishova A, Antonova L, Khapchaev Y, Feldblium I, Ivanova O, Siniugina A, Ishmukhametov A. Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine "PoliovacSin": Clinical Trials Phase I and II. Vaccines (Basel) 2021;9:565. [PMID: 34072466 DOI: 10.3390/vaccines9060565] [Reference Citation Analysis]
2 Shi L, Sun M. The progress of postapproval clinical studies on Sabin IPV. Hum Vaccin Immunother 2021;:1-4. [PMID: 34213408 DOI: 10.1080/21645515.2021.1940653] [Reference Citation Analysis]